The Europe Vaccines Market is expected to reach US$ 16,291.0 Mn in 2027 from US$ 9,576.2 Mn in 2018. The market is estimated to grow with a CAGR of 5.5% from 2019-2027.

Europe Vaccines Market Introduction

The European vaccines market is currently expanding, fueled by increasing awareness programs about vaccination and a rise in vaccines research and development initiatives throughout Europe. Conversely, persistent vaccine hesitancy in the region is expected to curb market growth over the forecast period.

Vaccination is crucial for public health, preserving lives and enhancing well-being. Take Polio, caused by poliovirus, which induces muscle weakness and diminishes life quality. The polio vaccine creates antibodies to provide protection. Extensive promotion of the polio vaccine enabled the WHO to declare Europe polio-free in 2002, showcasing vaccination's profound impact.

European nations are uniting to eliminate infectious diseases such as measles, diphtheria, and rubella via vaccination. Numerous vaccination programs, campaigns, and conferences are organized to boost public awareness. European Immunization Week (EIW), celebrated annually in April, underscores the vital role of vaccination. The ECDC backs the WHO/Europe's EIW campaign by offering scientific validation for vaccination.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00005750

Europe Vaccines Strategic Insights

Strategic insights for the Europe Vaccines market offer a data-driven analysis of the sector, covering prevailing trends, major players, and regional differences. These insights deliver actionable recommendations, empowering stakeholders to gain a competitive edge by spotting unexplored market segments or crafting distinctive value propositions. Utilizing data analytics, these insights help industry participants foresee market changes. A forward-looking perspective is vital for stakeholders to predict market shifts and secure long-term success. Ultimately, effective strategic insights enable readers to make well-informed decisions that boost profitability and achieve business goals in the market.

EUROPE VACCINES MARKET - SEGMENTATION

Europe Vaccines Market - By Technology

• Recombinant vaccines
• Conjugate Vaccines
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines

EUROPE VACCINES MARKET - By Disease Indication

• DTP (diphtheria, tetanus, and pertussis)
• Influenza
• Hepatitis
• Other Diseases

EUROPE VACCINES MARKET – By Rout of Administration

• Oral
• Injectable
• Other

EUROPE VACCINES MARKET - By Patient Type

• Adults
• Pediatric

EUROPE VACCINES MARKET - By Country

• Germany
• France
• UK
• Italy
• Spain       

 EUROPE VACCINES MARKET - Companies Mentioned

• PFIZER INC
• GlaxoSmithKline plc.
• Merck & Co., Inc.
• Sanofi
• Johnson & Johnson Services, Inc
• Panacea Biotec Limited
• Astellas Pharma Inc.
• NOVAVAX, INC.
• VBI Vaccines Inc
• Bavarian Nordic

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications